UPDATE : Wednesday, June 19, 2019
Handok gets shares in TRIGR Therapeutics
Handok said Monday that it has invested $5 million to acquire shares in TRI...
by Lee Han-soo  |  2019-03-18 12:02
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo  |  2019-03-15 15:39
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun  |  2019-03-15 15:38
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo  |  2019-03-15 13:21
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im  |  2019-03-15 11:41
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo  |  2019-03-13 17:48
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo  |  2019-03-13 15:43
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo  |  2019-03-13 12:43
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi  |  2019-03-13 12:43
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo  |  2019-03-13 10:49
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo  |  2019-03-12 18:02
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo  |  2019-03-12 17:46
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im  |  2019-03-12 16:17
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo  |  2019-03-12 13:55
HanAll starts P3 clinical trials for dry eye treatment in US
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo  |  2019-03-12 10:41
Kolon gets FDA nod for testing gene therapy for neuropathic pain
Kolon Life Science said Monday it obtained the U.S. Food and Drug Administr...
by Jeong Sae-im  |  2019-03-11 17:01
LSK Global PS sets up subsidiary
LSK Global PS said Monday that it has established a subsidiary called LSK N...
by Lee Han-soo  |  2019-03-11 15:14
LG Chem to develop sextuple influenza vaccine
LG Science Park in Gayang-dong, Seoul. LG Chem said Monday that it has re...
by Lee Han-soo  |  2019-03-11 14:31
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo  |  2019-03-11 14:03
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo  |  2019-03-08 16:57
Back to Top